ACT in action.

Alexander Khoruts, M.D., with the University of Minnesota Medical School and M Health Fairview, is interviewed about gut health, why it’s important and how anyone can improve their gut health.

A French Documentary series, The Extraordinary Powers of the Human Body produced by Elephant / 17 Juin Media highlights the University of Minnesota Microbiota Therapeutics Program in Episode 4 “Stomach aches, depression, cancers: the microbiota revolution.” View the entire episode or watch the University of Minnesota segment at 1 hour 20 minutes. The segment shares the microbiota transplant therapy used for C. difficile patients, highlights Amanda Kabage’s healing experience after receiving a microbiota transplant and the process of creating microbiota therapeutics from donor to capsule.

A study at the University of Minnesota, supported by Achieving Cures Together, indicated Microbiota Transplant Therapy is safe in patients with acute myeloid leukemia and undergoing stem cell transplantation. In the randomized, double blind study, patients enrolled in the active treatment group received microbiota therapeutics after each round of antibiotics. Trial results indicate that patients receiving microbiota transplant therapy had reduced rate of infection compared to patients receiving the placebo, while not statistically significant.

St. Louis Park-based Achieving Cures Together will host a virtual event, Spread Hope, to hear from experts around the nation sharing highlights of their research and clinical trials that they say connects microbial health to autism, cancer recovery and gastrointestinal health. Guest speakers include Dr. Alexander Khoruts, Dr. James Adams, Dr. Rosa Krajmalnik-Brown, Dr. Byron Vaughn and Dr. Shernan Holtan.

For the U of M’s Microbiota Therapeutics Program team, this work is personal. Amanda Kabage’s life saving Intestinal Microbiota Transplant not only gave her health back, but a new career focus.

Achieving Cures Together is honored to be highlighted with Dr. Khoruts and the University of Minnesota’s Microbiota Therapeutics Program for our development of encapsulated microbiota.